RT Book, Section
A1 McGowan, Michelle L.
A1 Fishler, Kristen
A1 Dryburgh, David Edul
A1 Saito, Kenji
A2 Quang, Tony S.
A2 Taft, Michelle S.
A2 Beriwal, Sushil
SR Print(0)
ID 1191392548
T1 Genetic Testing
T2 Understanding the Principles and Practice of Legal Oncology
YR 2022
FD 2022
PB McGraw Hill Education
PP New York, NY
SN 9781260474077
LK hemonc.mhmedical.com/content.aspx?aid=1191392548
RD 2023/12/05
AB Both  germline  and  somatic  mutations  contribute  to  tumor  pathogenesis.  The  integration  of  genetic  and  genomic  sequencing  into  cancer  care  has  unveiled  the  presence  of  unique  mutations  that  characterize  tumors  based  on  their  molecular  origins.1  In  some  cases,  specific  molecularly  targeted  therapies  may  be  incorporated  into  a  personalized  treatment  plan  based  on  the  presence  of  a  particular  mutation  biomarker.2–5